Deschloroketamine
1Provenance card
the boundary, as counts
Sources
2521 with DOI
1 strong · 17 moderate · 7 weak
Compilations
12026-04-27T00:57:45.711Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
57last ruled 2026-06-04
0 awaiting a ruling
Issued documents
42026-10-19T20:31:22.013Z
notice · info card · emergency
Searches
202 with no results
queries and counts on the build
Claims checked
8269 supported
69 supported · 13 not
Correspondence
0received
consent field ships in Phase 4
Edges
278
derivations recorded for this entity
Complete over 25 sources, 1 compilation, and 57 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/deschloroketamine/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued info_card
- 2026-09-12revisionr1.a1
- 2026-09-07srcSynthesis and identification of deschloroketamine metabolites in rats' urine and a quantification method for deschloroketamine and metabolites in rats' serum and brain tissue using liquid chromatography tandem mass spectrometry
- 2026-09-07srcStudies on the Stability and Microbial Biotransformation of Five Deschloroketamine Derivatives as Prerequisite for Wastewater-Based Epidemiology Screening
- 2026-09-07srcCharacterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance
- 2026-09-07src1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances
- 2026-09-07srcDesigner drugs: mechanism of action and adverse effects
- 2026-09-07srcEmergence of new psychoactive substance 2-fluorodeschloroketamine: Toxicology and urinary analysis in a cluster of patients exposed to ketamine and multiple analogues
- 2026-09-07srcMethod development for the identification of methoxpropamine, 2-fluoro-deschloroketamine and deschloroketamine and their main metabolites in blood and hair and forensic application
- 2026-09-07srcFatal intoxication related to two new arylcyclohexylamine derivatives (2F-DCK and 3-MeO-PCE)
- 2026-09-07srcPrevalence study of drugs and new psychoactive substances in hair of ketamine consumers using methanolic direct extraction prior to high-resolution mass spectrometry
- 2026-09-07srcKetamine analogues: Comparative toxicokinetic in vitro-in vivo extrapolation and quantification of 2-fluorodeschloroketamine in forensic blood and hair samples
- 2026-09-07srcBasic metabolic and vascular effects of ketamine and its interaction with fentanyl
- 2026-09-07srcRewarding and reinforcing effects of two dissociative-based new psychoactive substances, deschloroketamine and diphenidine, in mice
- 2026-09-07srcZebrafish embryo-larval testing reveals differential toxicity of new psychoactive substances
- 2026-09-07srcNew/emerging psychoactive substances and associated psychopathological consequences
- 2026-09-07srcSynthesis, absolute configuration and in vitro cytotoxicity of deschloroketamine enantiomers: rediscovered and abused dissociative anaesthetic
- 2026-09-07srcReports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review
- 2026-09-07srcCharacterization of extensive 2-fluorodeschloroketamine metabolism in pooled human liver microsomes, urine and hair from an addicted patient
- 2026-09-07src2-Fluorodeschloroketamine consumption: About two deaths and a case of self-mutilation
- 2026-09-07srcPharmacokinetic, pharmacodynamic, and behavioural studies of deschloroketamine in Wistar rats
- 2026-09-07srcPhencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
- 2026-09-07srcIn Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry
- 2026-09-07srcNorketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord
- 2026-09-07srcDeschloroketamine — PsychonautWiki
- 2026-09-07srcDeschloroketamine NPS Discovery Monograph
- 2026-09-07srcDeschloroketamine Erowid Experience Vault Index
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-06-04proposal54 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-04-27revisionRevision 1
- 2026-04-27absenceSearched ClinicalTrials.gov for "deschloroketamine" — no results
- 2026-04-27absenceSearched ClinicalTrials.gov for "deschloroketamine" — no results
- 2026-04-27genGeneration — pipeline-v5 · with 1 morepipeline-v5
- 2026-04-27rungeneration run
The same entries, as forms: six forms.